IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study
Kim Papp, Mark Weinberg, A. O. Morris, Kristian Reich
Topics & Concepts
Plaque psoriasisPlaceboMedicineDermatologyPsoriasisInternal medicinePathologyAlternative medicinePsoriasis: Treatment and PathogenesisMonoclonal and Polyclonal Antibodies ResearchBiosimilars and Bioanalytical Methods